KURE vs. PPH
Compare and contrast key facts about KraneShares MSCI All China Health Care Index ETF (KURE) and VanEck Vectors Pharmaceutical ETF (PPH).
KURE and PPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. KURE is a passively managed fund by CICC that tracks the performance of the MSCI China All Shares Health Care 10/40 Index. It was launched on Feb 1, 2018. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011. Both KURE and PPH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
KURE vs. PPH - Performance Comparison
Loading graphics...
KURE vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
KURE KraneShares MSCI All China Health Care Index ETF | 0.18% | 24.87% | -17.83% | -17.70% | -25.43% | -16.01% | 68.97% | 34.30% | -30.07% |
PPH VanEck Vectors Pharmaceutical ETF | 0.69% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -9.55% |
Returns By Period
In the year-to-date period, KURE achieves a 0.18% return, which is significantly lower than PPH's 0.69% return.
KURE
- 1D
- 1.67%
- 1M
- -2.79%
- YTD
- 0.18%
- 6M
- -15.23%
- 1Y
- 13.79%
- 3Y*
- -4.11%
- 5Y*
- -12.05%
- 10Y*
- —
PPH
- 1D
- 1.94%
- 1M
- -7.00%
- YTD
- 0.69%
- 6M
- 15.81%
- 1Y
- 16.30%
- 3Y*
- 12.44%
- 5Y*
- 10.59%
- 10Y*
- 8.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
KURE vs. PPH - Expense Ratio Comparison
KURE has a 0.65% expense ratio, which is higher than PPH's 0.36% expense ratio.
Return for Risk
KURE vs. PPH — Risk / Return Rank
KURE
PPH
KURE vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for KraneShares MSCI All China Health Care Index ETF (KURE) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| KURE | PPH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.48 | 0.83 | -0.35 |
Sortino ratioReturn per unit of downside risk | 0.82 | 1.26 | -0.44 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.16 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 0.62 | 1.48 | -0.86 |
Martin ratioReturn relative to average drawdown | 1.31 | 4.08 | -2.77 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| KURE | PPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.48 | 0.83 | -0.35 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.38 | 0.72 | -1.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.48 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.06 | 0.31 | -0.37 |
Correlation
The correlation between KURE and PPH is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
KURE vs. PPH - Dividend Comparison
KURE's dividend yield for the trailing twelve months is around 4.19%, more than PPH's 1.77% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KURE KraneShares MSCI All China Health Care Index ETF | 4.19% | 4.19% | 1.29% | 0.65% | 0.05% | 14.12% | 0.00% | 0.25% | 0.21% | 0.00% | 0.00% | 0.00% |
PPH VanEck Vectors Pharmaceutical ETF | 1.77% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Drawdowns
KURE vs. PPH - Drawdown Comparison
The maximum KURE drawdown since its inception was -68.53%, which is greater than PPH's maximum drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for KURE and PPH.
Loading graphics...
Drawdown Indicators
| KURE | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.53% | -51.45% | -17.08% |
Max Drawdown (1Y)Largest decline over 1 year | -22.72% | -10.02% | -12.70% |
Max Drawdown (5Y)Largest decline over 5 years | -67.94% | -20.26% | -47.68% |
Max Drawdown (10Y)Largest decline over 10 years | — | -29.70% | — |
Current DrawdownCurrent decline from peak | -56.38% | -7.00% | -49.38% |
Average DrawdownAverage peak-to-trough decline | -37.67% | -17.38% | -20.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.71% | 4.14% | +6.57% |
Volatility
KURE vs. PPH - Volatility Comparison
KraneShares MSCI All China Health Care Index ETF (KURE) has a higher volatility of 9.06% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 5.11%. This indicates that KURE's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| KURE | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.06% | 5.11% | +3.95% |
Volatility (6M)Calculated over the trailing 6-month period | 17.78% | 12.37% | +5.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.85% | 19.67% | +9.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.89% | 14.85% | +17.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.52% | 16.95% | +15.57% |